Finance

Lists
BLRX:NASDAQ
BioLine RX Ltd - ADR
2,32 USD
-1,69%
(-0,040) 1D
2,18 USD
-6,03% (-0,14)
After hours
Closed: 30-сен., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLRX...
Open
2,36 USD
High
2,40 USD
Low
2,30 USD
Mkt. cap
12,45 млн
Avg. vol.
22,32 миң
Volume
40,78 миң
52-wk high
4,56 USD
52-wk low
2,16 USD
EPS
-0,49 USD
Beta
1,56
Shares outstanding
4,98 млн
No. of employees
22
Open
2,36 USD
High
2,40 USD
Low
2,30 USD
Mkt. cap
12,45 млн
Avg. vol.
22,32 миң
Volume
40,78 миң
52-wk high
4,56 USD
52-wk low
2,16 USD
EPS
-0,49 USD
Beta
1,56
Shares outstanding
4,98 млн
No. of employees
22
News stories
From web sources and news partners
Profile
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
About BioLine RX Ltd - ADR
CEOPhilip A. Serlin
Employees22
Founded2003
Headquarters-
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to BLRX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for BLRX in the last 3 months
Highest
Current 2,32 USD
26,00 USD (+1 020,69%)
Average
26,00 USD (+1 020,69%)
Lowest
26,00 USD (+1 020,69%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
26,00 USD
+1 020,7%
08/31/2026
Justin Walsh
JonesTrading
Buy
Reiterated
12,00 USD
+417,2%
06/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
427,00 миң
194,00 миң
477,00 миң
294,00 миң
Cost of goods sold
84,00 миң
40,00 миң
95,00 миң
59,00 миң
Cost of revenue
84,00 миң
40,00 миң
95,00 миң
59,00 миң
Research and development expenses
1,72 млн
2,42 млн
2,53 млн
2,94 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
831,00 миң
1,12 млн
858,00 миң
865,00 миң
Operating expense
2,55 млн
3,54 млн
3,39 млн
3,81 млн
Total operating expenses
2,63 млн
3,58 млн
3,48 млн
3,87 млн
Operating income
-2,21 млн
-3,39 млн
-3,00 млн
-3,57 млн
Other non operating income
1,16 млн
1,10 млн
458,00 миң
-690,00 миң
EBT including unusual items
-977,00 миң
-2,24 млн
-2,59 млн
-4,34 млн
EBT excluding unusual items
-977,00 миң
-2,24 млн
-2,59 млн
-4,34 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-977,00 миң
-1,38 млн
-1,60 млн
-3,03 млн
Net profit margin
-228,81%
-713,92%
-335,64%
-1 029,25%
Earnings per share
-
-
-
-
Interest and investment income
377,00 миң
-
208,00 миң
132,00 миң
Interest expense
-304,00 миң
-288,00 миң
-250,00 миң
-208,00 миң
Net interest expenses
73,00 миң
-288,00 миң
-42,00 миң
-76,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,09 млн
-3,33 млн
-2,92 млн
-3,50 млн
Gain or loss from assets sale
-
25,00 миң
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору